Hey, neighbor, I thought I'd weigh in on STEM:
stockcharts.com[PA][DA][F!3!2.0!]&pref=G
P&F wise it needs to go through 2.40 to head higher, though the bearish resistance line, and therefore the breakout point, will drop if we get some backing and filling in the near term.
GERN and some gene therapy companies such as TLRK, SGMO, and ARIA have more substance to them than STEM, I think. Not that GERN and ARIA haven't been accused of blowing smoke a few times... TLRK is a blue sky breakout now, while SGMO is still fighting some resistance around 5.80. ARIA has a court date with LLY next week that could really send ARIA flying (unless the court clips the wings). GERN has bottomed and is in good position to move up. There's a major biotech conference next week, and the biotech sector looks like it wants to break out of a long consolidation period. And that will be good for STEM, as well, so your suggestion doesn't have all that much downside in this environment.
Another stem cell type of play is CRXL. It gapped up today, but that one has a fire under it, I think. |
